Transparency data
Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 25 February 2021 to 6 April 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 February 2021 to 6 April 2021.
Documents
PDF, 238 KB, 10 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 294 KB, 12 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 237 KB, 10 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 331 KB, 11 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 222 KB, 8 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 363 KB, 12 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 259 KB, 9 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 285 KB, 13 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 279 KB, 9 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
As part of our ongoing mission to improve transparency, we are publishing minutes taken from meetings of the Commission on Human Medicines’ Vaccine Benefit Risk Expert Working Group (VBREWG) between 25 August 2020 and 5 May 2023. The VBREWG meetings focused on evaluating the safety, efficacy, and overall benefits versus risks of vaccines, providing expert advice and recommendations on licensing and regulatory action.
Under Section 40 and 43 of the Freedom of Information Act respectively, personal data of individuals and commercially sensitive information has been redacted from these minutes.
Updates to this page
Published 9 December 2024